This legislation aims to establish an interagency task force to enhance collaboration between the United States Patent and Trademark Office (USPTO) and the Food and Drug Administration (FDA). The primary goal is to improve the sharing of information and provide technical assistance concerning patents, particularly those related to human drugs and biological products, thereby streamlining processes for the pharmaceutical and biotechnology industries. The key provisions include the creation of the task force, which will facilitate communication between the USPTO and FDA.